Serial changes of serum KL-6 predict the short-term prognosis in rapidly progressive IPF [16], and initial serum KL-6 levels are associated with long-term survival in IPF and pulmonary fibrosis in connective-tissue disease [17-21]. This evidence concerns the gene MUC1 and pulmonary fibrosis.